For the Quarter Ending December 2022
The North American market for Streptomycin Sulphate experienced fluctuating sentiment in the fourth quarter of 2022 due to varying demand from downstream pharmaceutical sectors. Streptomycin Sulphate prices in the US market increased by 7.6% till November and were estimated at USD 36115/MT; however, prices marginally decreased to USD 35445/MT in December. There were supply chain interruptions from a major exporting country, primarily China, due to the Golden Week holiday in the early week of October and subsequent Covid limitations. Though, the orders from downstream pharmaceutical companies were high due to low stocks, which boosted trader confidence in the domestic market. By the quarter's conclusion, increased import frequency from Chinese ports resulted in sufficient market supply, which caused the cost to be slightly lower. Additionally, a decline in market dynamics resulted from sluggish demand and a subdued consumer mindset before the Christmas holiday.
In the Asia Pacific region, the Streptomycin Sulphate market revealed an assorted sentiment with price fluctuations during the entire fourth quarter of 2022. An increment of 5.3% in Streptomycin Sulphate's price trend was seen in the first half of Q4, with prices settling at USD 33250/MT in November. Low inventories among domestic merchants as a result of the suspension of manufacturing activities over the Golden Week holidays in the first week of October encouraged the upward price trend in the market. Also, the lockdown in Shanghai with rising COVID cases continued to make exports of API unstable. Later, the demand from the downstream pharmacy sector began to decline due to orders being uneven, resulting in a drop in the prices in the second half of Q4. Thus, by the quarter ending December, prices of Streptomycin Sulphate were estimated at USD 32455/MT in China.
Streptomycin Sulphate had oscillating market dynamics during Europe's fourth quarter of 2022. Streptomycin Sulphate prices in the German market rose to USD 37455/MT till November due to reduced import activity from China over the Golden Week vacation and zero Covid-19 limitations, resulting in low supplies in the local market. Streptomycin Sulphate prices, however, fell 2.4% in December, settling at USD 36560/MT in Germany due to declining demand from the downstream pharmaceutical and nutraceutical sectors, which had impacted the German market's fundamentals and led to a price reduction. Domestic retailers also had adequate inventory to fulfill demand generally, which led to a downward trend towards the end of the quarter.
For the Quarter Ending September 2022
In North America, after Streptomycin Sulphate API CFR Houston prices in the US market settled at $35650/mt in July, debates only dwindled until the middle of the third quarter, when they once more declined and settled at $33520/MT in September. Given that this product is mainly imported as a medicinal ingredient, China's zero-covid policy severely restricted its availability throughout the country. However, domestic retailers had enough stock to satisfy all downstream demand. Due to the heat wave and a power shortage, some Chinese manufacturing facilities were forced to close during the second half of Q3, which had an adverse impact on US commerce and further weakened demand.
The domestic Streptomycin Sulphate market trend in the APAC region declined in the third quarter of 2022 as FOB Shanghai prices in China dropped to USD 30050 per MT in August before rising to USD 31560 per MT in September. The low demand in the pharmaceutical industry during the first half of the quarter had a substantial impact on the price chart for this product. However, significant suppliers delayed making large orders because of unforeseen events like the country's severe weather and power disruptions. Later, in the second half, the pharma industry's demand improved. Following the suspension, some manufacturing facilities underwent maintenance when the markets reopened, which also had a detrimental impact.
In Europe, the third quarter of 2022 began with a rise in the CFR Hamburg price trend for Streptomycin Sulphate API in Germany, whose prices were assembled at $37650 per MT in July and then later declined to USD 34905 per MT in September. The instability in Russia and Ukraine, as well as the lockdown and port restrictions in China, added to the already challenging economic climate in Europe (a major supplier). Additionally, the end-user pharmaceutical industries' offtakes were sluggish in the first half of this quarter which later got worsened in the latter weeks of September.
The prices for Streptomycin Sulphate API increased in the second quarter of 2022 with a surge in downstream demand in the North American region. Increased demand from the pharmaceuticals sector amid limited supply in the market resulted in a rise in the price trend. Moreover, disruptions in the market activities of Streptomycin Sulphate API were seen in the second quarter owing to the high logistics and fuel costs amidst a high inflation rate. Prices increased in June due to hampered manufacturing activities and delays in the North American region. Market players passed the rise of input costs to the downstream buyers in the local market during the Q2 of 2022. Towards the end of Q2 of 2022, Streptomycin Sulphate prices were assessed at USD 34290/MT for CFR Houston.
In the Asia Pacific region, the price of Streptomycin Sulphate API showcased an upward trend in Q2 2022 due to firm demand from the pharmaceutical sector. The prices raised in the Indian market due to crippled availability in the domestic market and an unexpected increment in the raw material costs among their production units. Moreover, a surge in the number of cases of Tuberculosis treatment also supported the increment in the demand fundamentals of Streptomycin Sulphate. Meanwhile, excipient prices have risen amidst the two-nations conflicts hampering the supply-demand chain elevated the price momentum of the product during the second quarter of 2022. Thus, Streptomycin Sulphate prices settled at INR 3100604/MT for Ex-Vapi towards the end of Q2 of 2022
In the European region, the Streptomycin Sulphate API market showcased a bullish sentiment during the second quarter of 2022, with the demand for treatment of Tuberculosis and infection-based products surging in the downstream pharmaceutical sector during this quarter. Moreover, the prices of Streptomycin Sulphate API increased in the second quarter due to a rise in the raw material prices in the regional market. The conflict between Russia and Ukraine throughout the quarter disrupted the overseas supplies for the product. It increased transportation charges amid high crude oil and natural gas prices, consequently causing upward pressure on the costs of the API. Thus, Streptomycin Sulphate prices were evaluated at USD 35880/MT for CFR Hamburg in June 2022